Myocardial localization of coronavirus in COVID-19 cardiogenic shock

European Journal of Heart Failure

Volumn 22, Issue 5, 2020, Pages 911-915

  Tavazzi, Guido ^a,b   Pellegrini, Carlo ^a,b   Maurelli, Marco ^b   Belliato, Mirko ^b   Sciutti, Fabio ^b   Bottazzi, Andrea ^b   Sepe, Paola Alessandra ^c   Resasco, Tullia ^c   Camporotondo, Rita ^b   Bruno, Raffaele ^a,b   Baldanti, Fausto ^a,b   Paolucci, Stefania ^b   Pelenghi, Stefano ^b   Iotti, Giorgio Antonio ^a,b   Mojoli, Francesco ^a,b   Arbustini, Eloisa ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

Author keywords

Cardiac injury; Cardiogenic shock; Coronavirus; Extracorporeal membrane oxygenation; Myocardial inflammation; SARS CoV 2

Indexed keywords

EPINEPHRINE; NORADRENALIN;

AGED; ARTERIAL GAS; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS DISEASE 2019; COUGHING; DYSPNEA; ECHOCARDIOGRAPHY; ENDOTRACHEAL INTUBATION; EXTRACORPOREAL OXYGENATION; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERLACTATEMIA; HYPOTENSION; HYPOXEMIA; INFLAMMATION; KLEBSIELLA PNEUMONIAE INFECTION; LYMPHOCYTOPENIA; MALE; METABOLIC ACIDOSIS; MYOCARDITIS; NONINVASIVE VENTILATION; PRIORITY JOURNAL; PSEUDOMONAS PNEUMONIA; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RESPIRATORY DISTRESS; SEPTIC SHOCK; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; THROAT CULTURE; WEAKNESS; ARTIFICIAL VENTILATION; BETACORONAVIRUS; BIOPSY; CARDIAC MUSCLE; COMPLICATION; CORONAVIRUS INFECTION; HEART; HEART FAILURE; ISOLATION AND PURIFICATION; PANDEMIC; PATHOLOGY; VIROLOGY; VIRUS PNEUMONIA;

AGED; BETACORONAVIRUS; BIOPSY; CORONAVIRUS INFECTIONS; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART; HEART FAILURE; HUMANS; MALE; MYOCARDITIS; MYOCARDIUM; PANDEMICS; PNEUMONIA, VIRAL; RESPIRATION, ARTIFICIAL; SHOCK, CARDIOGENIC;

EID: 85083865650     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.1828     Document Type: Article

References (15)

1. Huang C, Wang Y, Li X, Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.
2. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061–1069.
3. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020;109:531–538.
4. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol 2020 Mar 27. https://doi.org/10.1001/jamacardio.2020.1286 [Epub ahead of print].
5. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020 Mar 27. https://doi.org/10.1001/jamacardio.2020.1096 [Epub ahead of print].
6. Alsaad KO, Hajeer AH, Al Balwi M, Al Moaiqel M, Al Oudah N, Al Ajlan A, AlJohani S, Alsolamy S, Gmati GE, Balkhy H, Al-Jahdali HH, Baharoon SA, Arabi YM. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection – clinicopathological and ultrastructural study. Histopathology 2018;72:516–524.
7. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY; SARS Study Group. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319–1325.
8. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 2020;323:1843–1844.
9. Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, Shah RV, Sims DB, Thiene G, Vardeny O; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation 2020;141:e69–e92.
10. van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation 2017;136:e232–e268.
11. Lorusso R, Centofanti P, Gelsomino S, Barili F, Di Mauro M, Orlando P, Botta L, Milazzo F, Actis Dato G, Casabona R, Casali G, Musumeci F, De Bonis M, Zangrillo A, Alfieri O, Pellegrini C, Mazzola S, Coletti G, Vizzardi E, Bianco R, Gerosa G, Massetti M, Caldaroni F, Pilato E, Pacini D, Di Bartolomeo R, Marinelli G, Sponga S, Livi U, Mauro R, Mariscalco G, Beghi C, Miceli A, Glauber M, Pappalardo F, Russo CF; GIROC Investigators. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience. Ann Thorac Surg 2016;101:919–926.
12. MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA 2020 Feb 19. https://doi.org/10.1001/jama.2020.2342 [Epub ahead of print].
13. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1720.
14. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani L, Schwartz A, Uriel N. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation 2020 Mar 21. https://doi.org/10.1161/CIRCULATIONAHA.120.046941 [Epub ahead of print].
15. Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, Cron RQ, Opal SM. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med 2016;44:275–281.